Page 12«..11121314..20..»

Category Archives: ALS Treatment

Tunnel to Towers and The Home Depot Foundation Partner to Provide Financial Support to 3 US Veterans – GlobeNewswire

Posted: Published on December 16th, 2020

December 16, 2020 15:46 ET | Source: Stephen Siller Tunnel To Towers Foundation photo-release Staten Island, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Tunnel to Towers Foundation and The Home Depot Foundation today announced that they have teamed up to provide financial assistance to three of our nations veterans this holiday season. Continue reading

Posted in ALS Treatment | Comments Off on Tunnel to Towers and The Home Depot Foundation Partner to Provide Financial Support to 3 US Veterans – GlobeNewswire

Mitsubishi Tanabe Pharma America Announces Initiation of Postmarketing Commitment Study Assessing Daily Dosing of Oral Edaravone in Patients with ALS…

Posted: Published on December 15th, 2020

JERSEY CITY, N.J., Dec. 14, 2020 /PRNewswire/ --Mitsubishi Tanabe Pharma America, Inc. Continue reading

Posted in ALS Treatment | Comments Off on Mitsubishi Tanabe Pharma America Announces Initiation of Postmarketing Commitment Study Assessing Daily Dosing of Oral Edaravone in Patients with ALS…

QurAlis’ Selective Kv7 Opener, a Drug Candidate for ALS, Demonstrates up to 20-Fold Increase in Potency and Dramatic Reduction in Side Effects…

Posted: Published on December 15th, 2020

CAMBRIDGE, Mass.--(BUSINESS WIRE)--QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced the results of extensive pre-clinical studies on its lead program, QRA-244, for ALS patients. QRA-244 is a Kv7.2/7.3 ion channel opener optimized for both safety and efficacy as a potential treatment for motor neuron hyperexcitability-induced neurodegeneration in ALS patients Continue reading

Posted in ALS Treatment | Comments Off on QurAlis’ Selective Kv7 Opener, a Drug Candidate for ALS, Demonstrates up to 20-Fold Increase in Potency and Dramatic Reduction in Side Effects…

How John Stamos and Wife Caitlin McHugh Are Using Their Platforms to Spark Change Surrounding ALS Treatment – WUSA9.com

Posted: Published on December 15th, 2020

How John Stamos and Wife Caitlin McHugh Are Using Their Platforms to Spark Change Surrounding ALS Treatment Caitlin McHugh Stamos is committed to enacting change. "It's all I think about now," the 34-year-old actress tells ET exclusively, while opening up about her recent efforts to amplify research, funding and treatment options for ALS patients. Alongside her husband, John Stamos, the couple is working around the clock to spread awareness andencourage others to join their fight. Continue reading

Posted in ALS Treatment | Comments Off on How John Stamos and Wife Caitlin McHugh Are Using Their Platforms to Spark Change Surrounding ALS Treatment – WUSA9.com

San Diego’s Locanabio raises $100 million for treatments aimed at degenerative diseases – The San Diego Union-Tribune

Posted: Published on December 15th, 2020

Locanabio, a San Diego gene therapy company focused on treatments for severe neurodegenerative diseases such as Huntingtons and Lou Gehrigs disease, has raised $100 million in a second round of venture capital funding. Continue reading

Posted in ALS Treatment | Comments Off on San Diego’s Locanabio raises $100 million for treatments aimed at degenerative diseases – The San Diego Union-Tribune

Aural Analytics, Inc. Announces the Launch of a Large-Scale Pivotal Study for Its Respiratory and Speech Motor Control Prediction Software Tools -…

Posted: Published on December 15th, 2020

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aural Analytics, Inc., the industry leader in speech neuroscience and speech analytics technologies, announced today the initiation of a multi-product pivotal study to demonstrate the safety and efficacy of its speech-based tools for measuring pulmonary function and speech motor function in amyotrophic lateral sclerosis (ALS). The company anticipates submitting the results of this multi-site, multi-language, 280 participant, prospective, blinded study to the U.S Continue reading

Posted in ALS Treatment | Comments Off on Aural Analytics, Inc. Announces the Launch of a Large-Scale Pivotal Study for Its Respiratory and Speech Motor Control Prediction Software Tools -…

Research Roundup: Huntington’s Mutation Linked to Frontotemporal Dementia and ALS and More – BioSpace

Posted: Published on December 15th, 2020

Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones Continue reading

Posted in ALS Treatment | Comments Off on Research Roundup: Huntington’s Mutation Linked to Frontotemporal Dementia and ALS and More – BioSpace

Target ALS Launches The First-Ever Comprehensive Research Initiative to Discover Urgently Needed ALS Biomarkers – Business Wire

Posted: Published on December 15th, 2020

NEW YORK--(BUSINESS WIRE)--Today, Target ALS launched the first-ever comprehensive effort to discover ALS biomarkers The Target ALS Diagnosis Initiative through which the organization will invest $15 million in collaborative grantmaking and the development of new scientific resources. The initiative was developed in response to input from over 100 scientists, patients, caregivers and other thought leaders. Continue reading

Posted in ALS Treatment | Comments Off on Target ALS Launches The First-Ever Comprehensive Research Initiative to Discover Urgently Needed ALS Biomarkers – Business Wire

Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and…

Posted: Published on December 15th, 2020

SAN DIEGO, Dec. 14, 2020 /PRNewswire/ --Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, today announced a $100 million Series B financing. Continue reading

Posted in ALS Treatment | Comments Off on Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and…

NJ woman urges Congress to pass ALS bill as she fights for her life – WPIX 11 New York

Posted: Published on December 15th, 2020

NUTLEY, N.J. Continue reading

Posted in ALS Treatment | Comments Off on NJ woman urges Congress to pass ALS bill as she fights for her life – WPIX 11 New York

Page 12«..11121314..20..»